comparemela.com

Latest Breaking News On - Ar asset management inc - Page 9 : comparemela.com

Concorde Asset Management LLC Cuts Position in NVIDIA Co (NASDAQ:NVDA)

Concorde Asset Management LLC cut its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 31.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,017 shares of the computer hardware maker’s stock after selling 2,807 shares during the period. NVIDIA comprises approximately 1.5% of Concorde Asset […]

Aisling Capital Management LP Lowers Stake in Marker Therapeutics, Inc (NASDAQ:MRKR)

Aisling Capital Management LP lowered its stake in shares of Marker Therapeutics, Inc. (NASDAQ:MRKR – Free Report) by 90.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 314,286 shares of the company’s stock after selling 2,828,571 shares during the quarter. Marker Therapeutics […]

AR Asset Management Inc Boosts Stock Holdings in Organon & Co (NYSE:OGN)

AR Asset Management Inc. lifted its stake in shares of Organon & Co. (NYSE:OGN – Free Report) by 49.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 109,955 shares of the company’s stock after acquiring an additional 36,500 shares during the quarter. AR Asset […]

AR Asset Management Inc Raises Stock Holdings in Bank of Hawaii Co (NYSE:BOH)

AR Asset Management Inc. boosted its position in shares of Bank of Hawaii Co. (NYSE:BOH – Free Report) by 2.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 63,240 shares of the bank’s stock after purchasing an additional 1,740 shares during the quarter. […]

40,700 Shares in Marker Therapeutics, Inc (NASDAQ:MRKR) Acquired by AR Asset Management Inc

AR Asset Management Inc. purchased a new position in Marker Therapeutics, Inc. (NASDAQ:MRKR – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 40,700 shares of the company’s stock, valued at approximately $29,000. Separately, Renaissance Technologies LLC increased its stake in Marker Therapeutics […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.